Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INEBILIZUMAB-CDON Cause Urinary tract infection? 17 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Urinary tract infection have been filed in association with INEBILIZUMAB-CDON. This represents 4.8% of all adverse event reports for INEBILIZUMAB-CDON.

17
Reports of Urinary tract infection with INEBILIZUMAB-CDON
4.8%
of all INEBILIZUMAB-CDON reports
2
Deaths
7
Hospitalizations

How Dangerous Is Urinary tract infection From INEBILIZUMAB-CDON?

Of the 17 reports, 2 (11.8%) resulted in death, 7 (41.2%) required hospitalization, and 1 (5.9%) were considered life-threatening.

Is Urinary tract infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INEBILIZUMAB-CDON. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does INEBILIZUMAB-CDON Cause?

Neuromyelitis optica spectrum disorder (42) Headache (29) Covid-19 (21) Pain (21) Nausea (20) Pneumonia (20) Arthralgia (18) Fatigue (17) Product storage error (14) Hypoaesthesia (13)

What Other Drugs Cause Urinary tract infection?

ADALIMUMAB (6,375) LENALIDOMIDE (4,247) ETANERCEPT (3,915) OCRELIZUMAB (3,618) TOFACITINIB (3,179) METHOTREXATE (2,960) DALFAMPRIDINE (2,757) RITUXIMAB (2,579) CARBIDOPA\LEVODOPA (2,151) ABATACEPT (2,110)

Which INEBILIZUMAB-CDON Alternatives Have Lower Urinary tract infection Risk?

INEBILIZUMAB-CDON vs INEXIUM INEBILIZUMAB-CDON vs INFLIXIMAB INEBILIZUMAB-CDON vs INFLIXIMAB-ABDA INEBILIZUMAB-CDON vs INFLIXIMAB-AXXQ INEBILIZUMAB-CDON vs INFLIXIMAB-DYYB

Related Pages

INEBILIZUMAB-CDON Full Profile All Urinary tract infection Reports All Drugs Causing Urinary tract infection INEBILIZUMAB-CDON Demographics